Ubs Asset Management Americas Inc Guardant Health, Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 2,612,777 shares of GH stock, worth $111 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,612,777
Previous 3,344,037
21.87%
Holding current value
$111 Million
Previous $76.7 Million
4.1%
% of portfolio
0.02%
Previous 0.02%
Shares
22 transactions
Others Institutions Holding GH
# of Institutions
347Shares Held
120MCall Options Held
793KPut Options Held
1.85M-
Vanguard Group Inc Valley Forge, PA12.1MShares$514 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$479 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.42MShares$274 Million8.64% of portfolio
-
Baillie Gifford & CO5.45MShares$232 Million0.13% of portfolio
-
Cadian Capital Management, LP New York, NY5.22MShares$223 Million9.25% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.36B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...